Posted on

Thermo Fisher facing potential speed bump in Qiagen deal

Stephane Mardel, CEO of investment and advisory group United First Partners, tells Bloomberg that Thermo Fisher Scientific (TMO +1.2%) may have to boost its €39-per-share offer for Qiagen (QGEN -0.6%) after proxy advisor Glass Lewis recommended voting against “Top Up” resolutions.

TMO may have to sweeten its bid in order to ensure that enough QGEN shares are tendered. The current threshold is 75%.

The risk of the deal not going through appears minimal however.

Read More